What's Going to Be Hot at ESC 2022?
DELIVER, testing dapagliflozin in HFpEF, is a big draw, but there’s also buzz for REVIVED, INVICTUS, and early-stage drug trials.
Source: tctmd.com
Stay updated with breaking news from Stephan Windecker. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DELIVER, testing dapagliflozin in HFpEF, is a big draw, but there’s also buzz for REVIVED, INVICTUS, and early-stage drug trials.
Cardiologists have an in-person option again, with a full slate of sessions ahead for the 70th European Society of Cardiology Congress.
Your access to the latest cardiovascular news, science, tools and resources.